GenEp is a pre-clinical stage biotechnology company based on intellectual property assets.
GenEp has raised $4.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
GenEp's investors include 3B Future Health Fund, Virginia Innovation Partnership Corporation, UVA Licensing & Ventures Group, Angelini Lumira Biosciences Fund, PDI Ventures.
GenEp is headquartered in Charlottesville, United States.
GenEp is a pre-clinical stage biotechnology company based on intellectual property assets.
GenEp is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GenEp — Funding & Investors." VCBacked, July 31, 2024, https://www.vcbacked.co/company/genep. Accessed August 13, 2026.
VCBacked. (2024). GenEp — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/genep
{{cite web |title=GenEp — Funding & Investors |url=https://www.vcbacked.co/company/genep |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated